UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Journal of Alzheimer's disease, 2014-01, Vol.41 (2), p.615-631

2014

Volltextzugriff (PDF)

Rivastigmine for Alzheimer's disease

Cochrane database of systematic reviews, 2015-04 (4), p.CD001191

2015

Volltextzugriff (PDF)

Rivastigmine for Alzheimer's disease

Cochrane database of systematic reviews, 2009-01 (2), p.CD001191

2009

Volltextzugriff (PDF)

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

The Lancet (British edition), 2010-11, Vol.376 (9755), p.1829-1837

2010

Volltextzugriff (PDF)

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Journal of Alzheimer's disease, 2013-01, Vol.35 (2), p.349-361

2013

Volltextzugriff (PDF)

Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy

Nature communications, 2021-01, Vol.12 (1), p.132-8, Article 132

2021

Volltextzugriff (PDF)

Rivastigmine for Dementia Associated with Parkinson's Disease

The New England journal of medicine, 2004-12, Vol.351 (24), p.2509-2518

2004

Volltextzugriff (PDF)

Felbamate add-on therapy for drug-resistant focal epilepsy

Cochrane database of systematic reviews, 2019-08, Vol.8 (8), p.CD008295

2019

Volltextzugriff (PDF)

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

Neurology, 2007-07, Vol.69 (4 Suppl 1), p.S14

2007

Volltextzugriff (PDF)

Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review

Pharmacological research, 2010-06, Vol.61 (6), p.473-481

2010

Volltextzugriff (PDF)

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Cochrane database of systematic reviews, 2012-03, Vol.2014 (3), p.CD006504

2012

Volltextzugriff (PDF)

Felbamate as an add-on therapy for refractory partial epilepsy

Cochrane database of systematic reviews, 2017-07, Vol.7 (7), p.CD008295-CD008295

2017

Volltextzugriff (PDF)

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis

Drugs & aging, 2023-11, Vol.40 (11), p.953-964

2023

Volltextzugriff (PDF)

Residues and dissipation kinetics of carbendazim and diethofencarb in tomato (Lycopersicon esculentum Mill.) and intake risk assessment

Regulatory toxicology and pharmacology, 2016-06, Vol.77, p.200-205

2016

Volltextzugriff (PDF)

Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment

The Gerontologist, 2011-02, Vol.51 (1), p.17-27

2011

Volltextzugriff (PDF)

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine

International psychogeriatrics, 2009-10, Vol.21 (5), p.813-824

2009

Volltextzugriff (PDF)

Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System

Journal of the American Geriatrics Society (JAGS), 2009-11, Vol.57 (11), p.1997-2003

2009

Volltextzugriff (PDF)

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study

International clinical psychopharmacology, 2014-07, Vol.29 (4), p.216-223

2014

Volltextzugriff (PDF)

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

International journal of geriatric psychiatry, 2006-01, Vol.21 (1), p.17-28

2006

Volltextzugriff (PDF)

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Current Alzheimer research, 2022-01, Vol.19 (7), p.541-553

2022

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

Clinical pharmacology and therapeutics, 2008-01, Vol.83 (1), p.106-114

2008

Volltextzugriff (PDF)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

BMJ (Online), 2005-04, Vol.330 (7496), p.874

International edition, 2005

Volltextzugriff (PDF)

Response to Iraqi and Hughes

Journal of the American Geriatrics Society (JAGS), 2016-01, Vol.64 (1), p.242-243

2016

Volltextzugriff (PDF)

Rivastigmine in the treatment of Alzheimer's disease: an update

Clinical interventions in aging, 2007-01, Vol.2 (1), p.17-32

2007

Volltextzugriff (PDF)

1 – 25 von 410

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(262)

Publikationsform

Artikel
(407)
magazinearticle
(3)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(392)
Science & Technology
(324)
Life Sciences & Biomedicine
(322)
Rivastigmine
(256)
Phenylcarbamates
(193)
Cholinesterase Inhibitors - Adverse Effects
(189)
Female
(185)
Phenylcarbamates - Adverse Effects
(182)
Male
(179)
Alzheimer Disease - Drug Therapy
(164)
Aged
(163)
Cholinesterase Inhibitors - Therapeutic Use
(144)
Biological And Medical Sciences
(143)
Medical Sciences
(140)
Phenylcarbamates - Therapeutic Use
(134)
Neurosciences & Neurology
(124)
Clinical Neurology
(113)
Anticonvulsants - Adverse Effects
(112)
Treatment Outcome
(109)
Propylene Glycols - Adverse Effects
(108)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Rivastigmine for Alzheimer's disease

Rivastigmine for Alzheimer's disease

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy

Rivastigmine for Dementia Associated with Parkinson's Disease

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Felbamate add-on therapy for drug-resistant focal epilepsy

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Felbamate as an add-on therapy for refractory partial epilepsy

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis

Residues and dissipation kinetics of carbendazim and diethofencarb in tomato (Lycopersicon esculentum Mill.) and intake risk assessment

Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine

Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Response to Iraqi and Hughes

Rivastigmine in the treatment of Alzheimer's disease: an update

Suchergebnisse filtern